Cognition Therapeutics, Inc. (CGTX) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Second Quarter 2023 Earnings Conference Call. My name is Jenny, and I will be your conference operator today. This call is being recorded. I would like to turn the presentation over now to your host for today's call, Danielle Konzel-Boateng, Investor Relations for Cognition Therapeutics. Please proceed, Mr. Konzel-Boateng. Good morning and thank you for participating in Cognition Therapeutics conference call today. With me today are Lisa Ricciardi, President and Chief Executive Officer of Cognition Therapeutics, and John Doyle, Chief Financial Officer of Cognition. A press release detailing Cognition Therapeutics second quarter 2023 results is available on the investor section of our website at CogRx.com. We encourage everyone to read this morning's press release as well as Cognition's quarterly report on Form 10-Q which is now filed with the SEC and available on our website. In addition, this conference call is being webcast through the company's website and will be archived for 30 days. Please note, certain information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that during this call, management will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements. due to risk and uncertainties associated with the company's business. These forward-looking statements are qualified by the cautionary statements contained in Cognition's press release and SEC filings, including its quarterly report on Form 10-Q and previous filings. This conference call contains time-sensitive information that is accurate only as of the date ...